Navigation Links
ViroPharma's Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
Date:9/6/2011

EXTON, Pa., Sept. 6, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the European Commission has granted a Centralized Pediatric Use Marketing Authorization (PUMA) for Buccolam® (midazolam, oromucosal solution), for treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents, from 3 months to less than 18 years of age.  This action by the European Commission represents the first product approval through the centralized PUMA procedure since its inception.

In connection with the approval of Buccolam, ViroPharma will make an additional payment of 10 million Pounds Sterling (approximately $16.3 million based on the August 31, 2011 exchange rate) to the former owners of Auralis Limited.

"Prolonged acute convulsive seizures remain a significant and all-too-common health threat in the paediatric and adolescent populations," commented Prof. Lieven Lagae, of the Department of Paediatric Neurology at the University Hospitals KU Leuven in Belgium.  "Historically, these dangerous seizures have been managed with rectally-administered diazepam, which, while effective, presents certain challenges including social acceptance and difficulties in administration.  The approval of Buccolam provides a welcomed alternative for the physicians, families and caregivers of children and adolescents who suffer from these seizures, and will dramatically change the treatment paradigm in this population of patients."

Buccolam is oromucosal midazolam provided in a pre-filled, age-specific dose formulation for convenient buccal (i.e. via the cavity between the cheek and gum) delivery. Buccal midazolam has been shown in four clinical studies to be either comparable or superior in both its effectiveness and speed of onset of action to the current standard treatment, rectally-administered diazepam, for termi
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
2. Nautilus Neurosciences and Tribute Pharmaceuticals Announce Exclusive Canadian License for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine
3. Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Womens Health Market
4. Enox Biopharma, Inc. Will Be Granted its Foundation Patent
5. Winner Medical Granted the COTTON USA Mark
6. Patent Granted for Simbionix Procedure Rehearsal Studio™
7. XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
8. China Botanic Pharmaceutical Granted China Patent for Siberian Ginseng Extraction Process
9. ACT Granted EU Orphan Medicinal Product Designation for hESC-Derived RPE Cells for Treatment of Stargardts Disease
10. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
11. Enox Biopharma, Inc. Will Be Granted a Patent for the Delivery of Therapeutic Agents From Within Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... DIEGO , May 26, 2015 ... developing targeted therapeutic devices to address infectious diseases ... Joyce , Chief Executive Officer, will present at ... Thursday, May 28th.  Details of Aethlon Medical,s presentation ... Investor Conference Date: , Thursday, May 28, 2015Time: ...
(Date:5/26/2015)... , May 26, 2015 ViiV ... Inc. (CHAI) announced today that Aurobindo Pharma has submitted ... for Tentative Approval, to the Food and Drug Administration ... first ANDA for a generic version of dolutegravir, less ... for sale in the United States ...
(Date:5/26/2015)... Mass. , May 26, 2015  Respiratory ... 62 nd Annual Meeting of the Japanese ... of monitoring patient respiration in hospitals miss critical ... risks to patients. The findings conclude that respiratory ... Respiratory Motion, Inc. more consistently protects patients than ...
Breaking Medicine Technology:Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 2Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 3Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5
... 2010 HeartWare International, Inc. (Nasdaq: HTWR ... miniaturized circulatory support technologies that are revolutionizing the treatment ... Godshall is scheduled to make an investor presentation at ... December 7, 2010 at 9:00 a.m. Pacific Time (noon, ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced ... the UK has completed review of the Clinical Trial Application ... 673 for genetically-defined cancers.  The company expects to initiate a ... "BMN 673 has been proven to be highly active ...
Cached Medicine Technology:HeartWare to Present at the Canaccord Genuity Cardio/Diabetes & Obesity Conference 2MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers 2MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers 3
(Date:5/26/2015)... 26, 2015 In God’s Unstoppable Favor, ... as she writes an unforgettable story of how God ... life. The first black student to desegregate Evangeline Parish ... by some students, treated harshly by a few teachers, ... personal phone conversation with Dr. Martin Luther King, Jr. ...
(Date:5/26/2015)... 26, 2015 Dermatologic surgeons performed nearly ... according to survey results released today by the American ... cancer treatments and several cosmetic categories, 2014 totals were ... steady overall compared to 2013 figures. , For ... ranked as the most-performed procedure (3.08 million) by ASDS ...
(Date:5/26/2015)... York (PRWEB) May 26, 2015 The ... http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals who were ... the litigation’s June 11th Science Day. According to an ... of Louisiana, on May 21st, topics to be addressed ... drug, the use of blood test based testing with ...
(Date:5/26/2015)... Rochester, MN (PRWEB) May 26, 2015 ... years of debilitating nosebleeds and fainting spells, four of ... even leading to cardiac arrest. , Though she ... transfusion, she continues to dedicate her time to increasing ... mission. , “Had there been awareness, we could have ...
(Date:5/26/2015)... May 26, 2015 Last week, ... Mexico patients with MRI, Ultrasound, and CT services—was ... American College of Radiology. The center is now ... , In order to be eligible for ... of qualifications including personnel qualifications, adequacy of facility ...
Breaking Medicine News(10 mins):Health News:Grace Sibley Releases Second Book, God's Unstoppable Favor 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 4Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 3Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 4Health News:Rochester Woman Brings Awareness to Genetic Disease 2
... it as been found in a study that drinking coffee may ... consumption should be moderate. Its moderate consumption every day may lower ... studies in US had linked drinking more than two cups of ... chronic liver disease. ,This new study by Harvard School ...
... Australian scientists are of the opinion that older adults ... heart disease. // ,The researchers at the ... a high risk than those without asthma to suffer ... and cancer,The study’s lead author Dr. Robert Adams ...
... government is facing accusation from the Victorian Opposition for ... ,Reports are rife that almost one in ... of being discharged from the hospital, necessitating a re-admission. ... Government about mental health shortfalls, during the previous year. ...
... the socioeconomic status of an individual that determines the ... published in the March 15, 2006 issue of CANCER, ... ,The study found that education, community poverty, and income ... outcomes as did age, disease stage, and treatment method. ...
... public display of their affection here on Valentine's Day would ... some young lovers. ,Youngsters have got over the initial ... lovers by the Akhil Bharatiya Vidhyarthi Parishad (ABVP), the Vishwa ... move is now being welcomed by courting couples, who are ...
... their telephonic conversations to a minimal level owing to the ... federal bureau for radiation protection (BfS) in Salzgitter says people ... station in an area of their home where they do ... is a good example. ,The cordless telephones, which commonly ...
Cached Medicine News:
... model in the PM series is ... required for routine brightfield observation, both ... photography. Remarkably economical in,price, it offers ... mechanisms which meet the needs of ...
... digital FireWire camera system for high resolution ... provides images of the highest color fidelity, ... users can expect perfect images due to ... cooling and innovative readout modes. The Leica ...
This compact photomicrographic system assures simple operation to achieve the exposure accuracy required for sophisticated photomicrography in most research and clinical environments....
... Stains for Geometric Data Hemastainer. ... Stains are quality control tested ... ensure proper staining and absence ... applications for a minimum of ...
Medicine Products: